Variables | All patients | Analysis group | Validation group | P value |
---|---|---|---|---|
Sex F/M | 14/109 | 9/64 | 5/45 | 0.69 |
Age (years) | 57.94 ± 10.96 | 57.88 ± 10.03 | 58.02 ± 12.29 | 0.94 |
ALT (U/L) | 30 (8–471.1) | 27 (10–261) | 35.5 (8–471.1) | 0.30 |
AST (U/L) | 47 (13–544) | 38 (13–291) | 52.5 (16–544) | 0.06 |
TBiL (μmol/L) | 18.3 (8.5–457) | 17.8 (8.5–457.0) | 20.0 (8.9–113.2) | 0.41 |
ALB (g/L) | 36.53 ± 4.91 | 36.98 ± 4.78 | 35.87 ± 5.06 | 0.22 |
D-Dimer (mg/L) | 0.80 (0.10–15.61) | 1.1 (0.27–15.61) | 0.72 (0.10–13.95) | 0.23 |
PTA (%) | 80.62 ± 14.57 | 82.31 ± 12.92 | 78.14 ± 16.51 | 0.12 |
PLT (× 109/L) | 162.09 ± 99.10 | 161.96 ± 102.87 | 162.28 ± 94.37 | 0.97 |
AFP | 441.06 (1.33–1210.0) | 393.09 (1.33–1210.0) | 511.09 (1.5–1210) | 0.38 |
PIVKA-II (mAU/ml) | 278.13 (1.6–75,000.00) | 196.12 (12–75,000.00) | 514.86 (1.6–75,000) | 0.45 |
Liver cirrhosis | ||||
YES/NO | 105/18 | 30/5 | 75/13 | 0.95 |
Child-Pugh grade | ||||
A | 68 | 37 | 31 | 0.27 |
B | 55 | 36 | 19 | |
PVTT, type | ||||
I | 34 | 21 | 13 | 0.91 |
II | 51 | 30 | 21 | |
III | 19 | 12 | 7 | |
IV | 19 | 10 | 9 | |
BCLC stage | ||||
A | 12 | 9 | 3 | 0.48 |
B | 76 | 43 | 33 | |
C | 35 | 21 | 14 | |
HBsAg (COI) | 4578 (12.2–8657.0) | 4512 (12.2–7542.0) | 5221.5 (35–8657.0) | 0.38 |
HBeAg | ||||
Positive | 55 | 32 | 23 | 0.81 |
Negative | 68 | 41 | 27 | |
HBV-DNA (IU/L) | 7500.0 (0.0–4.16 × 107) | 5800.0 (0.0–4.16 × 107) | 21,750.0 (0.0–3.26 × 107) | 0.46 |